E*TRADE Financial Corp. (NASDAQ: ETFC) is going to be on our “multi-day exponential volume alerts” watch list for at least the next four trading sessions. The company sold 435 million shares in a secondary offering at $1.10 per share, a 23% discount to yesterday’s close and a far cry lower than the $1.90 at the [...]
Sinovac Biotech Ltd (AMEX: SVA) shares are up more than 10% on six times normal volume this morning after the company won a key H1N1 influenza virus vaccine pact. This is a vaccine supply pact for the government in Beijing and sounds as though it could be just the first of many ‘possible’ pacts. See [...]
Large drug stocks are testing four-month highs in early trading this morning, and are among the strongest stock groups. Most of the big names in the group including Pfizer (NYSE: PFE), Johnson & Johnson (NYSE: JNJ), Eli Lilly & Co. (NYSE: LLY) and Abbott Laboratories (NYSE: ABT) all are trading higher in the early going. One [...]
Solar energy stocks are mostly higher in premarket trading this morning, after UBS upgraded Sunpower Corporation (Nasdaq – SPWRA) to a Buy, calling it the best-positioned U.S. solar play. The positive sentiment is also spilling over to many other names in the group, as they all can potentially benefit from the same trends UBS says [...]
It appears that Cramer trumps the analysts. Despite a UBS downgrade on valuation late yesterday that many are seeing for the first time this morning, RF Micro Devices (Nasdaq – RFMD) is up in strong premarket trading as of 9 a.m. this morning, after the company’s CEO appeared on Cramer’s Mad Money last night, citing strong [...]
Smith & Wesson (Nasdaq – SWHC) is up 13% after the company guided higher after hours, and several analysts raised estimates for the stock this morning. Troubling times appear to be increasing demand for firearms. There are anecdotal reports in many regions around the country of gun stores posting strong double-digit pistol sales since the [...]
Palm (Nasdaq – PALM) is up about 3.5% as one of the most actives, after RIMM’s results seemed to reflect increased competition from Palm and its new Pre smartphone offering, despite its $0.04 earnings beat vs. consensus. By all accounts, preorders for the Pre continue to come in strong.
Microsoft (Nasdaq – MSFT) is up about 2% in the premarket. Media including Reuters reports that the stock’s price target was raised to $29 from $25 at Goldman Sachs, and it was added to the Americas Conviction Buy list.
Microsoft Corporation (NASDAQ: MSFT) is trading up almost 2% in the earlybird pre-market hours before the NASDAQ starts updating quotes. We have the market at $23.97 X $24.00 on over 126,000 shares as of 7:40 AM EST. The news is that is one of the top pre-market analyst upgrades and downgrades after Goldman Sachs added [...]